Humana Management of Acute Coronary Syndromes (Contemporary Cardiology)

In this second edition of his highly acclaimed book, Christopher P. Cannon, MD, and a team of preeminent clinical investigators have thoroughly revised and expanded every chapter to reflect the recent explosion of clinical trials on the management of acute coronary syndromes (ACS). This includes: the newer tests, such as C reactive protein; a multimarker approach to diagnosis and risk stratification; new antiplatelet agents; and combinations of thrombolytic-antithrombotic regimens. Also discussed are the latest developments in interventional cardiology, the use of cost-effectiveness in clinical trials to choose appropriate therapies, and the employment of critical pathways analysis to improve compliance with evidence-based medicine and guideline recommendations. Review Reviews of the first edition: Foreword by Eugene Braunwald, MD "The review of the data on the diagnostic and prognostic utility of serum markers of cardiac injury is especially thorough. The treatments of thrombolytic therapy and primary angioplasty for acute myocardial infarction are complete, timely, and objective...[the] section on special aspects of acute coronary syndromes summarizes well the important issues of gender bias (or lack thereof) in cardiovascular medicine and the impact of lowering cholesterol." -Annals of Internal Medicine "This is an excellent and concise review of the spectrum of unstable angina, ST segment elevation infarction, and ST segment depression infarction. . .It spends a good deal of time on explaining the serum markers for myocardial ischemia as well as their pathophysiologic differences between ST elevation and ST depression infarction and the rationale for specific treatment strategies. Data on primary angioplasty and the thrombolytic trials are reviewed in detail. . .The numerous tables and charts are well designed and emphasize important topics covered in the text. . .This book is an excellent summary of acute coronary syndromes. It is well thought out and easy to read, which allows the reader to assimilate a lot of information in a short period of time. Its clear writing and effective use of tables and graphics solidifies understanding this essential topic in cardiology."-5 stars, Doody's Health Sciences Book Review Journal "... an outstanding compendium of what is currently known about the etiology, diagnosis, and treatment of acute coronary syndromes....The chapter references are extensive and up-to-date. The illustration, tables and charts are well done and easily interpreted....In summary, this is an outstanding work that should be on the reading list of everyone who deals with cardiac care. Emergency physicians and cardiologists should read it from cover to cover and there is something for everyone here." -The Journal of Emergency Medicine "...a valuable resource for cardiologists and emergency physicians...will also serve residents, fellows, internists, and practicing physicians." -Circulation "...contains a large amount of useful information..." -Journal of Family Practice "...should be on the reading list of everyone who deals with cardiac care..." -Journal of Emergency Medicine "...an excellent summary of acute coronary syndromes...allows the reader to assimilate a lot of information in a short period of time." -Doody's Health Sciences Book Review Journal From the Back Cover In this second edition of his highly acclaimed book, Christopher P. Cannon, MD, and a team of preeminent clinical investigators have thoroughly revised and expanded every chapter to reflect the recent explosion of clinical trials on the management of acute coronary syndromes (ACS). These world-renowned experts review: the newer tests, such as C reactive protein; a multimarker approach to diagnosis and risk stratification; new antiplatelet agents; and combinations of thrombolytic-anti- thrombotic regimens. They also discuss the latest developments in interventional cardiology (ear